DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Betaseron (Interferon Beta-1B) - Current Clinical Trials

 
 



Betaseron Related Clinical Trials

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose [No longer recruiting]

BEYOND Follow-up: Betaferon«/Betaseron« Efficacy Yielding Outcomes of a New Dose [Active, not recruiting]

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose [Active, not recruiting]

Betaferon«/ Betaseron« (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy [Completed]

Follow-up Study of the BENEFIT Study (Betaferon« / Betaseron« in Newly Emerging Multiple Sclerosis for Initial Treatment) [Active, not recruiting]

Physical Disability in Patients Treated With Betaferon [Recruiting]

Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period [Recruiting]

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial. [Recruiting]

Natalizumab De-escalation With Interferon Beta-1b [Recruiting]

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon« in Korea [Not yet recruiting]

Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis [Recruiting]

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron« to Treat Relapsing-Remitting Multiple Sclerosis [Active, not recruiting]

Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH) [Recruiting]

Depression and Fatigue in MS Patients Treated With Betaferon. [Recruiting]

China Betaferon Adherence, Coping and Nurse Support Study [Recruiting]

Study Evaluating Betaferons´┐Ż Safety and Tolerability In Pediatric Patients With Multiple Sclerosis [Recruiting]

Combination Therapy of Betaseron-Prograf in Multiple Sclerosis [Active, not recruiting]

RNF and Betaseron« Tolerability Study [Active, not recruiting]

Safety Study in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif [Recruiting]

Betaseron Pregnancy Registry [Recruiting]

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms [Recruiting]

Betaferon« Regulatory Post-Marketing Surveillance [Recruiting]

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment [Recruiting]

Rehabilitation Study in MS Patients [Recruiting]

Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon [Recruiting]

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen [Completed]

Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis [Completed]

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250┬Ág in Patients of Chinese Origin With Multiple Sclerosis [Recruiting]

MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) [Not yet recruiting]

An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-Remitting MS [Completed]

Physical Activity and Fatigue in Early Multiple Sclerosis (MS) [Recruiting]

Phase IV, Rater-Blinded, Randomized Study, Comparing the Effects of 250 Mg of Betaseron With 20 Mg of Copaxone in Patients With the Relapsing-Remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-Dose Gadolinium [Active, not recruiting]

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis [Recruiting]

Clinical 15 Months Study Comparing Monthly Pulse ACTH (Acthar Gel) Therapy With Monthly Methylprednisolone (MP, Solumedrol) for Multiple Sclerosis (MS) Patients Who Are on Regular Beta-interferons (Avonex, Betaseron or Rebif) [Recruiting]

Study to Compare Double-Dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS) [Withdrawn]

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early MS Treatment With Betaseron [Recruiting]

Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron) [Completed]

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis [Terminated]

Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells [Recruiting]

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis [Recruiting]

BENEFIT Extension Study [Recruiting]

Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis [Recruiting]

Interferon ├č-1b Treatment by Cyclical Administration [Recruiting]

Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS [Completed]

Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon A Randomized Study [Recruiting]

Therapy Optimization in Multiple Sclerosis (MS) [Recruiting]

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma [Recruiting]

Patients With RRMS:Candidates for MS Therapy Change [Recruiting]

Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma [Completed]

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS [Completed]

Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis [Recruiting]

Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) [Recruiting]

A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis [Completed]

Gamma Interferon Therapy for Chronic Hepatitis C [Completed]

Optimizing IFN Beta - 1B Dose [Completed]

REsPonse to Interferon-Alpha in InterfeRon-╬▓ Neutralizing Antibody Positive Multiple Sclerosis Patients [Recruiting]

BG00012 Phase 2 Combination Study in Subjects With Multiple Sclerosis [Recruiting]

Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis [Not yet recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012